ES2958808T3 - Terapia de infecciones por virus del papiloma humano de alto riesgo - Google Patents

Terapia de infecciones por virus del papiloma humano de alto riesgo Download PDF

Info

Publication number
ES2958808T3
ES2958808T3 ES19765421T ES19765421T ES2958808T3 ES 2958808 T3 ES2958808 T3 ES 2958808T3 ES 19765421 T ES19765421 T ES 19765421T ES 19765421 T ES19765421 T ES 19765421T ES 2958808 T3 ES2958808 T3 ES 2958808T3
Authority
ES
Spain
Prior art keywords
composition
pharmaceutical composition
use according
acid
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES19765421T
Other languages
English (en)
Spanish (es)
Inventor
Norbert Fuchs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SELO MEDICAL GmbH
Original Assignee
SELO MEDICAL GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SELO MEDICAL GmbH filed Critical SELO MEDICAL GmbH
Application granted granted Critical
Publication of ES2958808T3 publication Critical patent/ES2958808T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES19765421T 2018-08-28 2019-08-28 Terapia de infecciones por virus del papiloma humano de alto riesgo Active ES2958808T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18191289.0A EP3616693A1 (en) 2018-08-28 2018-08-28 Therapy of high-risk human papillomavirus infections
PCT/EP2019/072926 WO2020043762A1 (en) 2018-08-28 2019-08-28 Therapy of high-risk human papillomavirus infections

Publications (1)

Publication Number Publication Date
ES2958808T3 true ES2958808T3 (es) 2024-02-15

Family

ID=63442535

Family Applications (1)

Application Number Title Priority Date Filing Date
ES19765421T Active ES2958808T3 (es) 2018-08-28 2019-08-28 Terapia de infecciones por virus del papiloma humano de alto riesgo

Country Status (25)

Country Link
US (2) US20210299163A1 (cg-RX-API-DMAC7.html)
EP (2) EP3616693A1 (cg-RX-API-DMAC7.html)
JP (1) JP7420791B2 (cg-RX-API-DMAC7.html)
CN (1) CN112584828A (cg-RX-API-DMAC7.html)
AR (1) AR116027A1 (cg-RX-API-DMAC7.html)
AU (1) AU2019332079B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021003360A2 (cg-RX-API-DMAC7.html)
CA (1) CA3107691C (cg-RX-API-DMAC7.html)
CL (1) CL2021000197A1 (cg-RX-API-DMAC7.html)
EA (1) EA202190441A1 (cg-RX-API-DMAC7.html)
ES (1) ES2958808T3 (cg-RX-API-DMAC7.html)
GE (2) GEP20227432B (cg-RX-API-DMAC7.html)
HR (1) HRP20231470T1 (cg-RX-API-DMAC7.html)
HU (1) HUE064691T2 (cg-RX-API-DMAC7.html)
IL (1) IL281080B2 (cg-RX-API-DMAC7.html)
MA (1) MA53482B1 (cg-RX-API-DMAC7.html)
MD (1) MD3843715T2 (cg-RX-API-DMAC7.html)
MX (1) MX2021002310A (cg-RX-API-DMAC7.html)
PL (1) PL3843715T3 (cg-RX-API-DMAC7.html)
RS (1) RS64916B1 (cg-RX-API-DMAC7.html)
SM (1) SMT202300340T1 (cg-RX-API-DMAC7.html)
TW (1) TWI827652B (cg-RX-API-DMAC7.html)
UA (1) UA127632C2 (cg-RX-API-DMAC7.html)
WO (1) WO2020043762A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202100375B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3875083A1 (en) * 2020-03-03 2021-09-08 Selo Medical GmbH Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
CN113304251A (zh) * 2021-03-04 2021-08-27 南京北极光生物科技有限公司 一种组合物在抗人乳头瘤病毒中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406377C (en) 2000-05-10 2010-07-06 Okopharm Forschungs-Und Entwicklungs-Gmbh Method for reducing the surface area of silicon dioxide
AT412758B (de) 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen
AT412448B (de) 2001-02-13 2005-03-25 Vis Vitalis Lizenz & Handels Verwendung von selenhältigen präparaten
AT412703B (de) * 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
AT511159A1 (de) * 2011-02-16 2012-09-15 Selo Medical Gmbh Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen

Also Published As

Publication number Publication date
SMT202300340T1 (it) 2023-11-13
IL281080B1 (en) 2024-08-01
EP3843715C0 (en) 2023-09-13
US20250281524A1 (en) 2025-09-11
US20210299163A1 (en) 2021-09-30
JP7420791B2 (ja) 2024-01-23
JP2021536454A (ja) 2021-12-27
PL3843715T3 (pl) 2024-02-19
HUE064691T2 (hu) 2024-04-28
MA53482A (fr) 2021-07-07
IL281080A (en) 2021-04-29
EP3616693A1 (en) 2020-03-04
GEP20227432B (en) 2022-10-25
CN112584828A (zh) 2021-03-30
ZA202100375B (en) 2024-08-28
AU2019332079A1 (en) 2021-02-11
TW202023534A (zh) 2020-07-01
EA202190441A1 (ru) 2021-06-15
MX2021002310A (es) 2021-04-28
MA53482B1 (fr) 2023-11-30
RS64916B1 (sr) 2023-12-29
AU2019332079B2 (en) 2024-08-29
MD3843715T2 (ro) 2023-12-31
EP3843715A1 (en) 2021-07-07
AR116027A1 (es) 2021-03-25
TWI827652B (zh) 2024-01-01
WO2020043762A1 (en) 2020-03-05
HRP20231470T1 (hr) 2024-03-01
UA127632C2 (uk) 2023-11-08
IL281080B2 (en) 2024-12-01
CA3107691C (en) 2024-10-29
GEAP202215586A (en) 2022-06-27
CA3107691A1 (en) 2020-03-05
BR112021003360A2 (pt) 2021-05-11
CL2021000197A1 (es) 2021-09-20
EP3843715B1 (en) 2023-09-13

Similar Documents

Publication Publication Date Title
US20250281524A1 (en) Therapy of high-risk human papillomavirus infections
CN107582563B (zh) 用于治疗子宫颈非典型性增生或子宫颈癌的包含亚硒酸盐或含亚硒酸盐化合物的药物制剂
ES2976058T3 (es) Composición para su uso en el tratamiento de las anomalías de las células cervicales que comprende compuesto de selenita y ácido
EA042677B1 (ru) Терапия папилломавирусных инфекций человека высокого риска
HK40045218A (en) Therapy of high-risk human papillomavirus infections
HK40045218B (en) Therapy of high-risk human papillomavirus infections
EA048333B1 (ru) Терапия папилломавирусных инфекций человека высокого риска
CA3167015C (en) Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
EA048159B1 (ru) Композиция для применения в лечении аномалий цервикальных клеток, содержащая селенитовое соединение и кислоту
HK40074763A (en) Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
HK40074763B (en) Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
HK1243360B (en) Pharmaceutical preparation containing selenite or selenite-containing compounds for the treatment of cervical dysplasias or carcinomas